ELECSYS ANTI-HBC IGM IMMUNOASSAY AND ELECSYS PRECICONTROL ANTI-HBC IGM

Test, Hepatitis B (b Core, Be Antigen, Be Antibody, B Core Igm)

FDA Premarket Approval P110031 S014

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

Relocation of manufacturing activities for the purification and production of antibodies and proteins and for the lyophilization of raw materials and addition of new lyophilization equipment.

DeviceELECSYS ANTI-HBC IGM IMMUNOASSAY AND ELECSYS PRECICONTROL ANTI-HBC IGM
Classification NameTest, Hepatitis B (b Core, Be Antigen, Be Antibody, B Core Igm)
Generic NameTest, Hepatitis B (b Core, Be Antigen, Be Antibody, B Core Igm)
ApplicantROCHE DIAGNOSTICS CORP.
Date Received2016-02-16
Decision Date2016-03-16
PMAP110031
SupplementS014
Product CodeLOM
Advisory CommitteeImmunology
Supplement Type30-day Notice
Supplement ReasonProcess Change - Manufacturer/sterilizer/packager/supplier
Expedited ReviewNo
Combination Product No
Applicant Address ROCHE DIAGNOSTICS CORP. 9115 Hague Road p.o. Box 50416 indianapolis, IN 46250-0457

Supplemental Filings

Supplement NumberDateSupplement Type
P110031Original Filing
S024 2018-10-26 Normal 180 Day Track No User Fee
S023 2018-10-09 30-day Notice
S022 2018-03-01 Real-time Process
S021
S020 2017-10-11 Real-time Process
S019 2017-08-03 30-day Notice
S018 2017-05-24 30-day Notice
S017 2016-12-07 Real-time Process
S016 2016-09-07 Normal 180 Day Track No User Fee
S015 2016-07-11 135 Review Track For 30-day Notice
S014 2016-02-16 30-day Notice
S013 2016-01-27 30-day Notice
S012 2016-01-27 135 Review Track For 30-day Notice
S011 2015-10-07 30-day Notice
S010 2013-07-19 Special (immediate Track)
S009
S008 2012-11-30 30-day Notice
S007
S006 2012-02-29 30-day Notice
S005 2012-02-02 30-day Notice
S004 2012-02-02 30-day Notice
S003 2012-02-02 30-day Notice
S002 2012-01-31 135 Review Track For 30-day Notice
S001 2012-01-31 Normal 180 Day Track No User Fee

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.